Pettit GR - Search Results

1

Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.

Kalemkerian GP, Ou X, Adil MR, Rosati R, Khoulani MM, Madan SK, Pettit GR. Kalemkerian GP, et al. Among authors: pettit gr. Cancer Chemother Pharmacol. 1999;43(6):507-15. doi: 10.1007/s002800050931. Cancer Chemother Pharmacol. 1999. PMID: 10321512

2

Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.

Ali MA, Rosati R, Pettit GR, Kalemkerian GP. Ali MA, et al. Among authors: pettit gr. Anticancer Res. 1998 Mar-Apr;18(2A):1021-6. Anticancer Res. 1998. PMID: 9615758

3

Effect of dolastatin 10 on human non-Hodgkin's lymphoma cell lines.

Maki A, Mohammad R, Raza S, Saleh M, Govindaraju KD, Pettit GR, al-Katib A. Maki A, et al. Among authors: pettit gr. Anticancer Drugs. 1996 May;7(3):344-50. doi: 10.1097/00001813-199605000-00016. Anticancer Drugs. 1996. PMID: 8792010

4

Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.

Aherne GW, Hardcastle A, Valenti M, Bryant A, Rogers P, Pettit GR, Srirangam JK, Kelland LR. Aherne GW, et al. Among authors: pettit gr. Cancer Chemother Pharmacol. 1996;38(3):225-32. doi: 10.1007/s002800050475. Cancer Chemother Pharmacol. 1996. PMID: 8646796

5

Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis.

Chen C, Lin H, Karanes C, Pettit GR, Chen BD. Chen C, et al. Among authors: pettit gr. Cancer Res. 2000 Aug 15;60(16):4377-85. Cancer Res. 2000. PMID: 10969781

6

The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.

Maki A, Diwakaran H, Redman B, al-Asfar S, Pettit GR, Mohammad RM, al-Katib A. Maki A, et al. Among authors: pettit gr. Anticancer Drugs. 1995 Jun;6(3):392-7. doi: 10.1097/00001813-199506000-00005. Anticancer Drugs. 1995. PMID: 7670136

7

In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE.

Woyke T, Pettit GR, Winkelmann G, Pettit RK. Woyke T, et al. Among authors: pettit rk, pettit gr. Antimicrob Agents Chemother. 2001 Dec;45(12):3580-4. doi: 10.1128/AAC.45.12.3580-3584.2001. Antimicrob Agents Chemother. 2001. PMID: 11709343 Free PMC article.

8

Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications.

Pettit GR, Flahive EJ, Boyd MR, Bai R, Hamel E, Pettit RK, Schmidt JM. Pettit GR, et al. Among authors: pettit rk. Anticancer Drug Des. 1998 Jan;13(1):47-66. Anticancer Drug Des. 1998. PMID: 9474242

9

Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.

Pettit GR, Srirangam JK, Barkoczy J, Williams MD, Durkin KP, Boyd MR, Bai R, Hamel E, Schmidt JM, Chapuis JC. Pettit GR, et al. Anticancer Drug Des. 1995 Oct;10(7):529-44. Anticancer Drug Des. 1995. PMID: 7495477

10

Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.

Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Al-Katib A. Mohammad RM, et al. Among authors: pettit gr. Clin Cancer Res. 1998 May;4(5):1337-43. Clin Cancer Res. 1998. PMID: 9607595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters